US Broker Ratings

Stoke Therapeutics, Inc. (STOK) Investor Outlook: Unpacking a Potential 135% Upside

For individual investors with an eye on the biotechnology sector, Stoke Therapeutics, Inc. (NASDAQ: STOK) presents an intriguing opportunity. This early-stage biopharmaceutical company, with a current..

Akso Health Group (AHG) Stock Analysis: Unveiling a 676% Revenue Growth in the Healthcare Sector

Akso Health Group (NASDAQ: AHG) is capturing significant attention within the healthcare sector, primarily due to its impressive 676% revenue growth. Operating from Qingdao, China, Akso..

Spyre Therapeutics, Inc. (SYRE): Analyst Consensus Points to a Potential 255% Upside for Innovative Biotech

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a biotech company headquartered in Waltham, Massachusetts, has captured the attention of investors with its promising pipeline of treatments for inflammatory..

Mind Medicine (MNMD) Stock Analysis: 246% Potential Upside Sparks Investor Interest

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a pioneering biopharmaceutical company, stands at the forefront of innovation in treating brain health disorders. Based in New York, this..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking a Potential 224% Upside in the Biotech Sector

Individual investors eyeing opportunities in the biotechnology sector might find REGENXBIO Inc. (NASDAQ: RGNX) an intriguing proposition. With a robust pipeline and significant potential for stock..

Savara, Inc. (SVRA) Stock Analysis: Unveiling a Promising 217.83% Upside Potential in the Biotech Sector

Savara, Inc. (NASDAQ: SVRA), a burgeoning name in the biotechnology sector, is making waves with its focus on rare respiratory diseases. Currently priced at $2.93, the..

iRadimed Corporation (IRMD) Stock Analysis: A 35.81% Upside Beckons for Healthcare Investors

iRadimed Corporation (IRMD), a prominent player in the healthcare sector specializing in MRI-compatible medical devices, is generating buzz among investors with its promising upside potential. With..

uniQure N.V. (QURE) Stock Analysis: Exploring a 133.81% Potential Upside in Biotechnology

As the biotechnology sector continues to capture investor attention, uniQure N.V. (NASDAQ: QURE) emerges as a compelling player with significant growth potential. Based in Amsterdam, Netherlands,..

Geron Corporation (GERN): Investor Outlook Highlights a 149% Potential Upside in the Biotech Sector

Geron Corporation (NASDAQ: GERN), a key player in the biotechnology sector, is capturing investor attention with its substantial potential upside of 149.16%. This California-based biopharmaceutical company..

Intellia Therapeutics (NTLA) Stock Analysis: A Potential 325% Upside in Gene Editing Biotech

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneering entity in the biotechnology sector, is currently capturing investor interest with its intriguing potential for significant upside. Despite a..

Ardelyx, Inc. (ARDX) Stock Analysis: Exploring a 172% Upside Potential in the Biotech Sector

Ardelyx, Inc. (NASDAQ: ARDX) stands as an intriguing prospect within the biotechnology sector, primarily driven by its innovative approach to addressing unmet medical needs. With a..

Avanos Medical, Inc. (AVNS) Stock Analysis: Exploring 12.18% Potential Upside Amid Challenging Market Dynamics

Avanos Medical, Inc. (NYSE: AVNS), a key player in the medical device industry, is currently navigating through a landscape characterized by both opportunities and challenges. With..

GH Research PLC (GHRS): Biotechnology with a Potential 206% Upside – Investor Insights

GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company based in Dublin, Ireland, is capturing the attention of investors with its ambitious approach to treating depression..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring the 82% Upside Potential in Biotech Innovations

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, California, is making waves in the healthcare sector with its innovative approach to immunology..

CureVac N.V. (CVAC) Stock Analysis: Exploring a 51% Upside in the mRNA Space

CureVac N.V. (CVAC), a pioneering biopharmaceutical company specializing in mRNA technology, has been making waves in the biotechnology sector with its innovative approach to developing transformative..

Iovance Biotherapeutics, Inc. (IOVA): Exploring a Potential 511% Upside in Biotech Innovation

For investors with a keen interest in the biotechnology sector, Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) represents an intriguing opportunity, particularly given its ambitious potential upside of..

Evolus, Inc. Common Stock (EOLS)

⚠️ No article content returned.

..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating a Potential 7.53% Upside Amid Healthcare Challenges

Community Health Systems, Inc. (NYSE: CYH) stands as a significant player in the healthcare sector, operating a network of general acute care hospitals across the United..

InnovAge Holding Corp. (INNV) Stock Analysis: Evaluating a 24.38% Upside Potential in Healthcare

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, is gaining attention among investors due to its significant upside potential. With a current..

Dianthus Therapeutics, Inc. (DNTH) Investor Outlook: Exploring a 179.96% Potential Upside in Biotechnology

For investors eyeing the healthcare sector, Dianthus Therapeutics, Inc. (NASDAQ: DNTH) offers an intriguing opportunity, particularly in the dynamic biotechnology industry. Headquartered in New York, this..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds